tiprankstipranks

Kenneth S. Robinson Insider Profile

4 Followers
Kenneth S. Robinson, Director at Oncternal Therapeutics, holds 44.10K shares in Oncternal Therapeutics (Ticker: ONCT).
tipranks
Kenneth S. Robinson

Kenneth S. Robinson
Oncternal Therapeutics (ONCT)
Director

Not Ranked
Kenneth S. Robinson has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$397K
100.00%
A breakdown of Kenneth S. Robinson's holdings

Insider Roles

Oncternal Therapeutics
(ONCT)
Director
Roles that Kenneth S. Robinson holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Kenneth S. Robinson

Kenneth S. Robinson's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Oncternal Therapeutics
Oct 02, 2018
Director
Uninformative Buy
13.37K
$396.94K
Kenneth S. Robinson has not reported any informative transactions for ONCT, therefore, performance cannot be measured.
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Apr 02, 2014
Uninformative Buy
$11.12K
-
$1.56
Jan 06, 2014
Uninformative Buy
$11.12K
-
$1.68
Jan 03, 2013
Uninformative Buy
$13.13K
-
$4.20
Apr 02, 2013
Uninformative Buy
$11.12K
-
$4.04
Jul 02, 2013
Uninformative Buy
$11.12K
-
$6.62
List of latest transactions for each holding click on a transaction to see Kenneth S. Robinson's performance on stock

Kenneth S. Robinson insider profile FAQ

What is the percentage of profitable transactions made by Kenneth S. Robinson?
The percentage of profitable transactions made by Kenneth S. Robinson is ―.
    What is the average return per transaction made by Kenneth S. Robinson?
    The average return per transaction made by Kenneth S. Robinson is ―.
      What stocks does Kenneth S. Robinson hold?
      Kenneth S. Robinson holds: ONCT stocks.
        What was Kenneth S. Robinson’s latest transaction?
        Kenneth S. Robinson latest transaction was an Uninformative Buy of $13.37K.
          What was Kenneth S. Robinson's most profitable transaction?
          Kenneth S. Robinson’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Kenneth S. Robinson's role in Oncternal Therapeutics?
            Kenneth S. Robinson's role in Oncternal Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.